New board appointment at Hemispherx BioPharma
This article was originally published in Scrip
Executive Summary
Thomas Equels, president and managing director of the Equels Law Firm, has been elected to the board of directors for Hemispherx BioPharma, a US biopharmaceutical company focused on the manufacture and clinical development of new drug entities for the treatment of viral and immune-based disorders.